Enterotoxigenic bacteroides fragilis
Enterotoxigenic bacteroides fragilis has been studied in 1 paper since 2026: none in people yet, 1 review; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, May 28, 2026: “Anti-ETBF = "Anti-aging"? Breaking the Microbial Loop of Human Mortality through Anti-Aging Vaccines”.
1 paper studies it2 findingsUpdated
See all 1 papers on enterotoxigenic bacteroides fragilis
What did studies of enterotoxigenic bacteroides fragilis find?
2Studies of enterotoxigenic bacteroides fragilis measured 2 outcomes: telomere attrition and E-CADHERIN.
Telomere attrition
upin humans1
1 study
Telomere attrition
upin humans1
Enterotoxigenic bacteroides fragilis increases telomere attrition in humans (proposed fragipain-fragilysin cascade).
“accelerates telomere attrition”
Reviewproposed fragipain-fragilysin cascade
Anti-ETBF = "Anti-aging"? Breaking the Microbial Loop of Human Mortality through Anti-Aging Vaccines
Zenodo (CERN European Organization for Nuclear Research)Preprint
E-CADHERIN
downin humans1
1 study
E-CADHERIN
downin humans1
Enterotoxigenic bacteroides fragilis decreases E-CADHERIN in humans (proposed fragipain-fragilysin cascade).
“permanently cleaves human E-cadherin barriers”
Reviewproposed fragipain-fragilysin cascade
Anti-ETBF = "Anti-aging"? Breaking the Microbial Loop of Human Mortality through Anti-Aging Vaccines
Zenodo (CERN European Organization for Nuclear Research)Preprint